SIRT or sorafenib in patients with locally advanced HCC: SARAH and SIRveNIB trials

Dr. Mohamed Bouattour from Hôpital Beaujon, APHP Clichy, France, discusses the SARAH and SIRveNIB trials in locally advanced HCC